Good news for people newly diagnosed with rare autoimmune disorder: Study finds low relapse risk
People newly diagnosed with myelin oligodendrocyte glycoprotein antibody-associated disease, or MOGAD, generally had a low risk of relapse and lasting disability, according to a Kaiser Permanente study. The work is published in the journal Neurology. If you liked the article, do not forget to share it with your friends. Follow us on Google News too, click on…